Immunohistochemical Study of beta-catenin Expression between Hepatocellular Carcinoma and Cholangiocarcinoma.
- Author:
Ki Jung YUN
1
;
Weon Cheol HAN
;
Suck Chei CHOI
;
Tae Hyeon KIM
Author Information
1. Department of Pathology, Wonkwang University School of Medicine, Iksan, Korea. kjyun@wonkwang.ac.kr
- Publication Type:Original Article
- Keywords:
Hepatocellular carcinoma;
Cholangiocarcinoma;
beta-catenin
- MeSH:
beta Catenin*;
Bile Ducts;
Carcinoma, Hepatocellular*;
Cell Membrane;
Cholangiocarcinoma*;
Formaldehyde;
Hepatocytes;
Liver;
Paraffin;
Signal Transduction
- From:Cancer Research and Treatment
2002;34(2):117-121
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: beta-catenin is an intracellular protein that is an integral component of the cadherin-mediated cell-cell interaction and a downstream transcriptional activator in the wnt signal transduction pathway. Inappropriate activation of beta-catenin has recently been implicated in the development of hepatocellular carcinoma and cholangiocarcinoma. Nuclear beta-catenin expression is strongly associated with gene mutation. This study was designed to evaluate the pattern of beta-catenin expression between hepatocellular carcinoma and cholangiocarcinoma. MATERIALS AND METHODS: Immunohistochemical expression of beta-catenin was studied in 7 normal livers, 33 hepatocellular carcinomas and 20 cholangiocarcinomas, that were formalin fixed and paraffin embedded. RESULTS: beta-catenin was expressed mainly in the cytoplasmic membrane of the normal hepatocytes and bile ducts. Nuclear expressions, not noted in the normal liver, were noted in 30% of the hepatocellular carcinomas and 10% of the cholangiocarcinomas. And, nuclear expression was more common in the high grade (50%) hepatocellular carcinomas than the low grade (18%) hepatocellular carcinomas (p<=0.05). CONCLUSION: The above results indicate that nuclear expression of beta-catenin is observed in the carcinoma but not the normal liver, and is associated with high grade liver carcinoma.
